Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Canaquest Medical Corp
(OP:
CANQF
)
0.0500
UNCHANGED
Streaming Delayed Price
Updated: 1:35 PM EDT, Aug 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Canaquest Medical Corp
NHL Alumni Association partners with CanaQuest and NEEKA Health to Conduct Studies for Anxiety and Quality of Life in former NHL Players
October 31, 2023
Via
ACCESSWIRE
CANAQUEST Announces Award of European Cannabinoid Patent
September 19, 2023
Via
ACCESSWIRE
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
July 26, 2023
Via
ACCESSWIRE
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
April 25, 2023
Via
ACCESSWIRE
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD
December 12, 2022
CanaQuest Achieves Statistically Significant Results in Reduction of Seizures for Epilepsy Compared to Standard CBD Drug Candidate, CQ-001 (cannabidiol "CBD" + IP formula), also demonstrated...
Via
iCrowdNewswire
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
December 08, 2022
Via
ACCESSWIRE
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
September 08, 2022
Via
ACCESSWIRE
CanaQuest Files International Mentanine(R) Patent, a Scientific CBD Formulation for Mental Health
April 29, 2021
TORONTO, ON / ACCESSWIRE / April 29, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing formulations...
From
CanaQuest Medical Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Exposures
Cannabis
Intellectual Property
Product Safety
CanaQuest Medical Corp Appoints Investor Relations and PR Veteran Rob Rinderman as its New Director of Communications
April 07, 2021
TORONTO, ON / ACCESSWIRE / April 7, 2021 / CANAQUEST MEDICAL CORP (OTC PINK:CANQF) (the "Company" or "CanaQuest"), an award-winning Life Science/Pharmaceutical company developing health and wellness...
From
CanaQuest Medical Corp.
Via
AccessWire
Topics
Cannabis
Initial Public Offering
Exposures
Cannabis
Securities Market
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.